APPLICATION
ANDA203063
TYPE
ANDA
ORIGINAL APPROVAL
2016-05-25
LATEST ACTION
2023-03-08
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued
Products
CLINDAMYCIN PALMITATE HYDROCHLORIDEDiscontinued
CLINDAMYCIN PALMITATE HYDROCHLORIDE EQ 75MG BASE/5ML · FOR SOLUTION · ORAL
Approval history
2023-03-08Labeling · Supplement 4 · standardAP
2023-03-08Labeling · Supplement 2 · standardAP
2023-03-08Labeling · Supplement 5 · standardAP
2023-03-08Labeling · Supplement 1 · standardAP
2016-05-25UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.